In March 2025, the company announced new strategies for just a immediate-to-client presenting of its Wegovy weight loss drug. The company set up a whole new pharmacy, referred to as NovoCare, which might charge clients $499 per month for entry to the drug, less than 50 % the cost of the drug through other pharmaceutical distribution networks.[53]We